Novartis
NVS
877 hedge funds and large institutions have $18.7B invested in Novartis in 2016 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 323 increasing their positions, 339 reducing their positions, and 43 closing their positions.
23% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 43
11% more call options, than puts
Call options by funds: $50M | Put options by funds: $45M
0.01% less ownership
Funds ownership: 10.04% → 10.03% (-0.01%)
0% less funds holding
Funds holding: 878 → 877 (-1)
4% less capital invested
Capital invested by funds: $19.5B → $18.7B (-$835M)
5% less repeat investments, than reductions
Existing positions increased: 323 | Existing positions reduced: 339
24% less funds holding in top 10
Funds holding in top 10: 37 → 28 (-9)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Parnassus Investments
San Francisco,
California
|
+$64.7M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$55.9M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$37.3M |
| 4 |
SEI Investments
Oaks,
Pennsylvania
|
+$25.2M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$21.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$125M |
| 2 |
JP Morgan Chase
New York
|
-$72.6M |
| 3 |
Dodge & Cox
San Francisco,
California
|
-$63.8M |
| 4 |
TH
TCTC Holdings
Dallas,
Texas
|
-$35.1M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
-$24.3M |
NVS Hedge Fund Activity: Q3 2016 in Review
877 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Novartis (NVS) for Q3 2016, worth a combined $18.7B — down 4.3% from $19.5B a quarter earlier.
Buyers outnumbered sellers: 53 funds opened new NVS positions and 43 closed out — a net gain of 10 holders — while 323 added to existing stakes and 339 trimmed.
The largest buyer was Parnassus Investments, adding an estimated $64.7M. The largest seller was Macquarie Group, cutting an estimated $125M.
- 877 institutional investors held Novartis (NVS) as of Q3 2016, down from 878 in Q2 2016.
- Funds reported $18.7B of Novartis stock for Q3 2016, down 4.3% quarter-over-quarter.
- 53 funds opened new Novartis positions in Q3 2016 and 43 closed out, a net change of +10 holders.
- The largest Novartis buyer in Q3 2016 was Parnassus Investments, an estimated $64.7M added.
- The largest Novartis seller in Q3 2016 was Macquarie Group, an estimated $125M sold.
Based on aggregated 13F filings for Q3 2016.